Vistagen Therapeutics, Inc. (NASDAQ:VTGN) filed a Form 8-K with the Securities and Exchange Commission on January 09, 2026, disclosing a material event. Vistagen Therapeutics,…
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) filed a Form 8-K with the Securities and Exchange Commission on January 09, 2026, disclosing a material event.
Vistagen Therapeutics, Inc.'s stock currently trades at $0.00 with a market capitalization of $0. The company's stock moved following the disclosure.
Current market data
NASDAQ · VTGN
$0.30
Up: +$0.00 · +0.34%
Live quote updated
Keep reading
sec_filing ·
earnings ·
price ·
earnings ·
